Table 2.
QoL, as assessed by the 15D© score, at baseline, follow-up, as change within-group from baseline for the TM and usual care groups and difference at follow-up between TM and usual care
TM group (N=141) | Usual care group (N=140) | |||
---|---|---|---|---|
15D baseline, mean (SD) | 0.735a (0.101) | 0.726a (0.113) | ||
15D 6-month follow-up, mean (SD) | 0.761b (0.107) | 0.728c (0.121) | ||
Within-group difference, mean | 0.016b (0.002–0.031)d p=0.03e | −0.003c (−0.018 to 0.012)d p=0.68e | ||
Between-group difference at follow-up, mean | 0.0222 (0.0049–0.0622)d p=0.02f | |||
TM + usual care groups stratified by baseline 15D score | <0.75 (N=62) | ≥0.75 (N=60) | <0.75 (N=71) | ≥0.75 (N=52) |
15D baseline, mean (SD) | 0.666 (0.065) | 0.824 (0.057) | 0.656 (0.076) | 0.834 (0.054) |
15D 6-months follow-up, mean (SD) | 0.703 (SD =0.095) | 0.819 (SD =0.083) | 0.661 (SD =0.100) | 0.819 (SD =0.082) |
15D change to 6-month follow-up, mean | 0.037 (0.016–0.059)d p=0.001e | −0.005 (−0.024 to 0.013)d p=0.569e | 0.006 (−0.015 to 0.026)d p=0.588e | −0.015 (−0.037 to 0.007)d p=0.186e |
Notes:
Nonsignificant difference.
Only 122 patients completed follow-up 15D.
Only 123 patients completed follow-up 15D.
95% confidence interval of the difference.
Paired t-test.
Analysis of covariance.
Abbreviations: QoL, quality of life; TM, telemonitoring.